RTOG-1203
Terminated
Protocol Information
Tab containing protocol details, study design, and eligibility criteria
Tab containing study documents, informed consent forms, and study materials
Tab containing information for potential study participants
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Principal Investigator
Status
Terminated
Open to Accrual
November 28, 2012
Closed to Accrual
August 27, 2015
Closed to Accrual & Treatment
October 26, 2015
Complete
July 17, 2017
Terminated
May 20, 2022
Disease Site
Gynecologic [GY] Other
Phase
III
Developmental Therapeutics
No
Primary Objective
To determine if IMRT reduces acute gastrointestinal toxicity in the 5th week (after 23-25 fractions) of pelvic radiation as measured with EPIC.
Patient Population
Pathologically proven diagnosis of endometrial and cervical cancer who require post-operative radiation or chemoradiation; Zubrod performance status of 0–2.
Target Accrual
281
Protocol Documents
Available via the National Cancer Institute (NCI) Cancer Trials Support Unit (CTSU) website.
Patient Study Webpage
There is no available patient study webpage available for this trial at this time.
-
Share this study.
-
-
-
-
